Our results show that FGF21 could protect HUVECs against ox-LDL-induced apoptosis and provide evidence that FGF21 hinders the exacerbation of atherosclerosis in apoE−/− mice, revealing that FGF21 is a metabolic disorder regulator for cardiovascular disease. The gene discussed is FGF21; the disease is metabolic disease.